Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8899
Corporate User License Price USD 375
Corporate User License Price INR 26696
Site License Price USD 250
Site License Price INR 17798
Request a Quote

Report Title

Interleukin Genetics Inc (ILIU)-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Interleukin Genetics Inc (ILIU)-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Interleukin Genetics Inc (ILIU)-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Interleukin Genetics Inc (ILIU)-Financial and Strategic SWOT Analysis Review



Executive Summary

Interleukin Genetics Inc (ILIU)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include PerioPredict genetic risk test; Weight management genetic test; Bone health genetic test; Heart health genetic test; Nutritional needs genetic test; and Wellness select genetic test. PerioPredict genetic test analyzes genetic variations that are associated with inflammation and helps in identifying individuals who are at increased risk for severe periodontal disease. Its genetic test product pipeline includes IL-1 genetic test for cardiovascular disease and osteoarthritis genetic test for osteoarthritis (OA). The company distributes its products through partnership with healthcare professionals, health and wellness companies, and distribution channels. Interleukin is headquartered in Waltham, Massachusetts, the US.

Interleukin Genetics Inc Key Recent Developments

May 12,2017: Interleukin Genetics Reports First Quarter 2017 Financial Results

Apr 18,2017: Interleukin Genetics Reports Fourth Quarter and Year-End 2016 Financial Results

Feb 23,2017: Interleukin Genetics Deploys ILUSTRA Inflammation Management Program with mPulse Mobile Employees

Feb 15,2017: IG and PBGH Forge Relationship To Bring ILUSTRATM To Pittsburgh Employers

Nov 15,2016: Interleukin Genetics Reports Third Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Interleukin Genetics Inc-Key Facts 6

Interleukin Genetics Inc-Key Employees 7

Interleukin Genetics Inc-Key Employee Biographies 8

Interleukin Genetics Inc-Major Products and Services 9

Interleukin Genetics Inc-Medical Equipment Pipeline Products Data 10

Interleukin Genetics Inc Pipeline Products by Equipment Type 10

Interleukin Genetics Inc Pipeline Products by Development Stage 11

Interleukin Genetics Inc-History 13

Interleukin Genetics Inc-Company Statement 15

Interleukin Genetics Inc-Locations And Subsidiaries 17

Head Office 17

Section 2-Company Analysis 18

Interleukin Genetics Inc-Business Description 18

Interleukin Genetics Inc-Corporate Strategy 19

Interleukin Genetics Inc-SWOT Analysis 20

SWOT Analysis-Overview 20

Interleukin Genetics Inc-Strengths 20

Interleukin Genetics Inc-Weaknesses 21

Interleukin Genetics Inc-Opportunities 22

Interleukin Genetics Inc-Threats 23

Interleukin Genetics Inc-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 31

Interleukin Genetics Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 32

Interleukin Genetics Inc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

May 12, 2017: Interleukin Genetics Reports First Quarter 2017 Financial Results 34

Apr 18, 2017: Interleukin Genetics Reports Fourth Quarter and Year-End 2016 Financial Results 35

Feb 23, 2017: Interleukin Genetics Deploys ILUSTRA Inflammation Management Program with mPulse Mobile Employees 37

Nov 15, 2016: Interleukin Genetics Reports Third Quarter 2016 Financial Results 38

Nov 03, 2016: Interleukin Genetics Launches The ILUSTRA Inflammation Management Program 40

Aug 16, 2016: Interleukin Genetics Reports Second Quarter 2016 Financial Results 41

Aug 03, 2016: Interleukin Genetics Strengthens Commercial Leadership with Key Appointments 43

May 16, 2016: Interleukin Genetics Reports First Quarter 2016 Financial Results 44

Mar 17, 2016: Interleukin Genetics Reports Fourth Quarter and Year-End 2015 Financial Results 46

Mar 16, 2016: Interleukin Genetics Appoints Global Clinical Advisory Board To Guide Enhanced Healthcare through Targeted Management of Systemic Inflammation 48

Section 6-Appendix 49

Methodology 49

Ratio Definitions 49

About GlobalData 53

Contact Us 53

Disclaimer 53

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Interleukin Genetics Inc Pipeline Products by Equipment Type 10

Interleukin Genetics Inc Pipeline Products by Development Stage 11

Interleukin Genetics Inc, Performance Chart (2012-2016) 28

Interleukin Genetics Inc, Ratio Charts 30

Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 31

Interleukin Genetics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 32

List of Tables

Interleukin Genetics Inc, Key Facts 6

Interleukin Genetics Inc, Key Employees 7

Interleukin Genetics Inc, Key Employee Biographies 8

Interleukin Genetics Inc, Major Products and Services 9

Interleukin Genetics Inc Pipeline Products by Equipment Type 10

Interleukin Genetics Inc Number of Pipeline Products by Development Stage 11

Interleukin Genetics Inc Pipeline Products Summary by Development Stage 12

Interleukin Genetics Inc, History 13

Interleukin Genetics Inc, Key Competitors 24

Interleukin Genetics Inc, Ratios based on current share price 25

Interleukin Genetics Inc, Annual Ratios 26

Interleukin Genetics Inc, Annual Ratios (Cont...1) 27

Interleukin Genetics Inc, Interim Ratios 29

Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 31

Interleukin Genetics Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 32

Interleukin Genetics Inc, Recent Deals Summary 33

Currency Codes 49

Capital Market Ratios 49

Equity Ratios 50

Profitability Ratios 50

Cost Ratios 51

Liquidity Ratios 51

Leverage Ratios 52

Efficiency Ratios 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person